Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07739602
NA

Effects of Cornelian Cherry Supplementation in Patients With Metabolic Syndrome

Sponsor: Wroclaw Medical University

View on ClinicalTrials.gov

Summary

This randomized, double-blind, placebo-controlled, parallel-group study evaluated the effects of six-month oral supplementation with Cornus mas fruit lyophilizate in patients with metabolic syndrome. Participants were assigned to receive either 8 g of Cornus mas fruit lyophilizate once daily or a matching placebo. Ophthalmic assessments included best-corrected visual acuity, slit-lamp examination, dilated fundus examination, applanation tonometry, and Doppler ultrasonography of the ophthalmic, central retinal, and posterior ciliary arteries. Cardiometabolic and biochemical parameters were also assessed at baseline and after 3 and 6 months of supplementation.

Official title: Effect of Oral Lyophilized Cornelian Cherry (Cornus Mas L.) Fruit on Selected Cardiometabolic, Vascular, Gut, Ocular and Bone Metabolism Parameters in Patients With Metabolic Syndrome.

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

55

Start Date

2019-01-17

Completion Date

2026-06-25

Last Updated

2026-07-31

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Placebo

A matching placebo formulation containing potato starch and sugar but no Cornus mas fruit lyophilizate, administered orally once daily for 6 months as a preparation made into a jelly.

DIETARY_SUPPLEMENT

Cornus mas Fruit Lyophilizate

A dietary supplement containing 8 g of lyophilized whole Cornus mas L. fruit, administered orally once daily for 6 months as a powder or granulate formulation prepared as a jelly.

Locations (1)

Department of Pharmacology, Wroclaw Medical University

Wroclaw, Poland